All these positive effects of the β2 adrenergic receptor are corroborated by the fact that deletion of the β2-AR gene ameliorates pathological effects in senile PS1/APP mice, indicating that β2AR may represent a potential therapeutic target for preventing the progression of AD [60]. The gene discussed is PSEN1; the disease is Alzheimer disease.